Ophthalmic Market Trends: US Retina Edition

Q2 - 2026

The Ophthalmic Market Trends: Quarterly US Retina Editions offer in-depth, quarterly insights into the ever-evolving US retina market. By surveying retina specialists and analyzing key metrics, these reports provide valuable data on retinal patient care, product usage, market share, and emerging trends. Each edition covers critical aspects such as IVT injections, DME treatments, vitrectomy volumes, and the adoption of both surgical equipment and pharmaceuticals like Eylea, Lucentis, and Avastin. With detailed trend analysis, full-year forecasts, and year-over-year comparisons, these editions are essential for making informed decisions and staying ahead in the retina care market.

The Ophthalmic Market Trends: Quarterly US Retina Editions measure and analyze key metrics of the US retinal market four times per year, including:

  • IVT injections by disease and product;
  • Use of Eylea, Lucentis, Avastin, Macugen, and Visudyne PDT;
  • DME treatments; 
  • Corticosteroid use;
  • Photocoagulation volume and photocoagulators used;
  • Vitrectomy volume and location;
  • Vitrectomy machine use and market share;
  • Reusable and disposable instruments.
  • Visualization agents

Our updates include trend analysis based on comparisons with information gathered in previous years. We also provide a full-year forecast for US retinal procedures (including IVT injections) and a comparison with volumes during the prior year. 

Beyond survey data, Market Scope sources additional information from our proprietary disease models, database of refractive and cataract specialists, primary research, and public data sources. In some cases, this additional information is used to extrapolate survey data to total market estimates. 

All Market Scope reports are continuously updated, and we appreciate your feedback at any time. If you have any questions or suggestions for improvements, please contact us.

2 licensing types are available for this subscription:

  • The price of the Yearly single-user license is $12,100.
  • The price of the Yearly enterprise license is $18,150.

SINGLE USER LICENSE

  • The Single User License allows for the use of a report by a single user within one corporate location.
  • The report paper copy may not be reproduced (additional paper copies available for purchase).
  • Report PDF copy can not be copied (if purchased) and must remain on one computer (not a company server).
  • Only a single copy of the publication may be printed for internal use.
  • Users may include information in the report in presentations and internal reports by providing full copyright credit to Market Scope.
  • Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

ENTERPRISE LICENSE

  • The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.
  • Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.
  • Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Market Scope.
  • Purchase price includes a printable PDF file of the report (purchasing organization may print multiple copies for use within the organization).
  • Purchase price includes a supplemental Excel file containing all the tables and figures included in the purchased report.

Pay by credit card or by invoice.

Related Reports

Want to Purchase the Full Report?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.